DrugDashboards

Methylprednisolone Acetate

Methylprednisolone Acetate · METHYLPREDNISOLONE ACETATE 40 mg/mL · Injection, Suspension · Intra-Articular; Intralesional; Intramuscular; Soft Tissue · Caplin Steriles Limited

NDC 65145-0192-25 · 25 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for methylprednisolone acetate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $19.14 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA220556
TE code
AB
Approval date
Jan 26, 2026
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)Jun 16, 2022
    Other
    month 51 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01)Dec 15, 2021
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)Dec 15, 2021
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03)Dec 15, 2021
    Other
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51)Dec 15, 2021
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52)Dec 15, 2021
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01)Dec 15, 2021
    Demand increase for the drug
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03)Dec 15, 2021
    Other
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22)Dec 15, 2021
    Demand increase for the drug
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23)Dec 15, 2021
    Other
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02)Dec 15, 2021
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12)Dec 15, 2021
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01)Dec 15, 2021
    Other
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03)Dec 15, 2021
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05)Dec 15, 2021
    Shortage of an active ingredient
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10)Dec 15, 2021
    Shortage of an active ingredient
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01)Dec 15, 2021
    Demand increase for the drug
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1)Dec 15, 2021
    Other
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5)Dec 15, 2021
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months
  • In shortage now — Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05)Dec 15, 2021
    Shortage of an active ingredient
    month 57 — 3× the typical 20-month injectable shortage · model puts 27% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Methylprednisolone Acetate (Injection, Suspension)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsMETHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCMETHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Sep 3, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Sep 3, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals NY LLCMETHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCMETHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.METHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedMETHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedMETHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCMETHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCMETHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE ACETATE 20 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsMETHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsMETHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsMETHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Aug 31, 2026
Sportpharm LLCMETHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Aug 31, 2026
Amneal Pharmaceuticals LLCMETHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Aug 28, 2026
Asclemed USA, Inc.METHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Aug 28, 2026
Endo USA, Inc.METHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Jul 31, 2026
Endo USA, Inc.METHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Jul 29, 2026
Sandoz Inc.METHYLPREDNISOLONE ACETATE 40 mg/mLJul 15, 2026Jul 29, 2026
Sandoz Inc.METHYLPREDNISOLONE ACETATE 80 mg/mLJul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Methylprednisolone Acetate — NDC 65145-0192-25," retrieved September 3, 2026, https://drugdashboards.com/drug/65145019225.

Free to cite with attribution — see how the data is put together.